• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

WHO Expert Committee on Biological Standardization. Thirtieth report.

出版信息

World Health Organ Tech Rep Ser. 1979(638):1-199.

PMID:120636
Abstract
摘要

相似文献

1
WHO Expert Committee on Biological Standardization. Thirtieth report.
World Health Organ Tech Rep Ser. 1979(638):1-199.
2
WHO Expert Committee on Biological Standardization. Thirty-second report.世界卫生组织生物标准化专家委员会。第三十二次报告。
World Health Organ Tech Rep Ser. 1982;673:1-180.
3
WHO Expert Committee on Biological Standardization. Thirty-fifth report.
World Health Organ Tech Rep Ser. 1985;725:1-140.
4
WHO expert committee on biological standardization.
World Health Organ Tech Rep Ser. 1981;658:1-325.
5
WHO Expert Committee on Biological Standardization. Forty-sixth Report.世界卫生组织生物标准化专家委员会。第四十六次报告。
World Health Organ Tech Rep Ser. 1998;872:i-vii, 1-90.
6
WHO Expert Committee on Biological Standardization.
World Health Organ Tech Rep Ser. 1989;786:1-184.
7
WHO Expert Committee on Biological Standardization. Twentieth report.
World Health Organ Tech Rep Ser. 1968;384:1-100.
8
WHO Expert Committee on Biological Standardization. Twenty-second report.
World Health Organ Tech Rep Ser. 1970;444:1-134.
9
WHO Expert Committee on Biological Standardization. Thirty-third report.
World Health Organ Tech Rep Ser. 1983;687:1-184.
10
WHO Expert Committee on Biological Standardization. Thirty-fourth report.
World Health Organ Tech Rep Ser. 1984;700:1-75.

引用本文的文献

1
Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.实验性和商业化百日咳疫苗在消除不同遗传特征的博德特氏菌在小鼠模型中的有效性。
Med Microbiol Immunol. 2021 Dec;210(5-6):251-262. doi: 10.1007/s00430-021-00718-1. Epub 2021 Aug 2.
2
Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.1997年和2007年瑞典儿童接种全细胞、双组分或五组分无细胞百日咳疫苗后以及患百日咳疾病后针对百日咳杆菌Fim2或Fim3的抗体反应。
Clin Vaccine Immunol. 2014 Feb;21(2):165-73. doi: 10.1128/CVI.00641-13. Epub 2013 Dec 4.
3
Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza.使用来自流感异源株的参考抗血清测定 H5N1 疫苗效力。
Influenza Other Respir Viruses. 2012 May;6(3):176-87. doi: 10.1111/j.1750-2659.2011.00285.x. Epub 2011 Sep 8.
4
Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.1970年至2003年期间，在瑞典，百日咳博德特氏菌变种在三个以不同疫苗接种计划为标志的时期内发生的变化。
J Clin Microbiol. 2005 Jun;43(6):2856-65. doi: 10.1128/JCM.43.6.2856-2865.2005.
5
Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods.使用单克隆抗体对百日咳博德特氏菌分离株进行血清分型：间接全细胞酶联免疫吸附测定法与细菌微量凝集法所得结果的比较
J Clin Microbiol. 2005 May;43(5):2449-51. doi: 10.1128/JCM.43.5.2449-2451.2005.
6
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.英国历史和近期临床分离株中百日咳博德特氏菌毒力因子百日咳黏附素和百日咳毒素的基因变异
Infect Immun. 2001 Sep;69(9):5520-8. doi: 10.1128/IAI.69.9.5520-5528.2001.